• Quotes
  • Shortcuts
The Executive's Internet
Fri, Oct 15th



Setup News Ticker
Searching for 'COVID-19 FDA'. (Return)

MarketWatch MarketPulseOct 15, 2021
FDA to hold advisory committee for Merck's experimental COVID-19 pill
Shares of Merck & Co. Inc. were down 0.1% in premarket trading on Friday, the day after the Food and Drug Administration said it plans to convene an advisory committee on Nov. 30 to discuss the company's experimental COVID-19 pill, molnupiravir. Merck is developing the antiviral with the privately held Ridgeback Biotherapeutics; it recently applied for emergency authorization. The FDA requested advisory committee meetings for each of the authorized COVID-19 vaccines but it did not convene one ahead of the authorizations of the monoclonal antibodies or Gilead Sciences Inc.'s remdesivir, an antiviral used to treat severely ill COVID-19 patients that is now fully approved. "We believe that, in this instance, a public discussion of these data with the agency's advisory committee will help ensure clear understanding of the scientific data and information that the FDA is evaluating to make a decision about whether to authorize this treatment for emergency use," Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in a statement. Merck's stock is up 0.4% for the year, while the S&P 500 has gained 18.1%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Google Business NewsOct 15, 2021
Independent FDA panel votes to authorize booster shots for Johnson & Johnson vaccine - ABC News
Independent FDA panel votes to authorize booster shots for Johnson & Johnson vaccine  ABC NewsFDA advisers endorse Moderna's COVID-19 vaccine booster shots  CBS NewsFDA vaccine advisers recommend emergency use authorization for booster dose of Moderna's Covid-19 vaccine  CNNOpinion | The Unvaccinated May Not Be Who You Think  The New York Times
stockBuy earnings Market dividend Virgin
ChinaLinkedIn record coal Evergrande Central
risefutures earnings sales retail prices
StocksBuy these earnings making biggest
recordChina coal rise futures weekly
salesretail September rise Dow consumers
pricesrise Energy oil China Higher
EarningsDow points Q3 Bank stocks
workersStrike Deere John contract Go
Capitalfund close Market View North

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2021 CEOExpress Company LLC